ASPI — ASP Isotopes Inc. Common Stock stock price, charts and financials

QT12ASP Isotopes Inc. Common Stock

ASP Isotopes Inc. Common Stock (NASDAQ: ASPI) is a Basic Materials company in the Chemicals - Specialty industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
3.04
-0.21-6.46%
ASPIQT12ASP Isotopes Inc. Common Stock·NASDAQ
3.04-6.46%
TA
Loading chart...
Screen all →
Snapshot
Index-P/E-EPS (ttm)-1.32Insider Own26.03%Shs Outstand125.90MPerf Week-8.16%
Market Cap382.75MForward P/E-EPS next Y-0.32Insider Trans-2.68%Shs Float108.99MPerf Month-25.67%
Enterprise Value397.75MPEG-EPS next Q-0.15Inst Own-Short Float23.38%Perf Quarter-57.66%
Income-133.00MP/S12.35EPS this Y64.39%Inst Trans-Short Ratio6.10Perf Half Y-30.43%
Sales31.00MP/B1.39EPS next Y31.91%ROA-23.08%Short Interest25.48MPerf YTD-43.18%
Book/sh2.18P/C1.50EPS next 5Y-ROE-63.49%52W High14.49 -79.02%Perf Year-65.26%
Cash/sh2.03P/FCF-EPS past 3/5Y-ROIC-17.29%52W Low3.04 0.00%Perf 3Y207.26%
Dividend Est.-EV/EBITDA-Sales past 3/5Y-Gross Margin18.32%Volatility5.92% 5.99%Perf 5Y-
Dividend TTM-EV/Sales12.83EPS Y/Y TTM-109.52%Oper. Margin-312.31%ATR (14)0.26Perf 10Y-
Dividend Ex-Date-Quick Ratio3.85Sales Y/Y TTM675.00%Profit Margin-428.00%RSI (14)31.87Recom2.00
Dividend Gr. 3/5Y-Current Ratio3.87EPS Q/Q-133.33%SMA20-18.19%Beta3.60Target Price9.50
Payout0.00%Debt/Eq0.83Sales Q/Q400.00%SMA50-23.58%Rel Volume3.08Prev Close3.25
Employees271LT Debt/Eq0.77EarningsNov 12SMA200-43.79%Avg Volume4.03MPrice3.04
IPO DateNov 10, 2022Option/ShortYes / YesEPS/Sales Surpr.-64.71% 2.42%Net Debt/EBITDA-0.39Volume12,423,041Change-6.46%
Analyst Ratings
DateActionAnalystRatingTarget
Dec-04-25InitiatedCantor FitzgeraldOverweight
Oct-27-25ReiteratedLoop Capital Markets
Oct-04-24InitiatedCanaccordBuy$4.50
Apr-17-24ReiteratedHC Wainwright & Co.Buy$5.50
Latest News· Times ET
Sep-08-26
Sep-01-26
Aug-21-26
Aug-20-26
Aug-19-26
Aug-18-26
Aug-17-26
Aug-12-26
Aug-06-26
Aug-05-26
Company

ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2019
12/31/2019
Total Revenue31244
Cost of Goods Sold Incl. D&A26203
Gross Profit532
Selling, General and Administrative Excl. Other804825
Research and Development22123
Other Operating Expense010
Operating Income-96-57-26
Interest Expense410
Unusual Expense
Non-Operating Income (Expense)-37-102-6
Net Income Before Taxes-137-160-32
Income Taxes
000
Consolidated Net Income-133-175-32
Net Income From Continuing Operations-137-160-32
Net Income-133-175-32
EPS (Recurring)-1.32-2.11-0.63
EPS (Basic, Before Extraordinaries)-1.32-2.11-0.63
EPS (Diluted)-1.32-2.11-0.63
EBITDA-129-157-32
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio
Price To Sales Ratio12.0618.5063.42
Gross Margin16.1312.5050.00
Operating Margin-309.68-237.50-650.00
Net Margin-429.03-729.17-800.00
Shares Outstanding1238356
Market Capitalization374444254
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$15.70$12.12$8.55$4.97$1.39 Close Price0.00M0.87M1.74M2.61M3.48MUSD Trades VolumeSepOctNovDec2026FebMarAprMayJunJulAugSep
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Ainscow RobertCOOSep 08 '26Sale4.298,43836,2162,248,441Sep 10
Mann Paul ElliotChairman and CEOSep 04 '26Sale4.1083,759343,4129,328,570Sep 04
Mann Paul ElliotChairman and CEOSep 03 '26Sale3.9283,758328,3319,412,329Sep 04
Ainscow Donald GeorgeEVP, Gen Counsel, SecretarySep 02 '26Sale3.8923,67892,107776,322Sep 04
Ainscow RobertCOOSep 02 '26Sale3.9025,00097,6252,256,879Sep 04
Mann Paul ElliotChairman and CEOSep 02 '26Sale3.9183,758327,4949,496,087Sep 04
Kiessling HeatherChief Financial OfficerJul 01 '26Sale6.2823,124145,2191,526,252Jul 02
Ainscow Donald GeorgeEVP, Gen Counsel, SecretaryJun 30 '26Sale6.14100,000614,000800,000Jul 02
Wider ToddDirectorJun 30 '26Sale6.1250,000306,000672,247Jul 01
Gorley MichaelDirectorJun 30 '26Sale6.2730,000188,10087,908Jul 01
Wider ToddDirectorJun 29 '26Sale6.2550,000312,500722,247Jul 01
Ainscow RobertCOOJun 08 '26Sale7.008,43859,0582,281,879Jun 10
Mann Paul ElliotChairman and CEOJun 03 '26Sale7.7683,759649,9709,579,845Jun 03
Mann Paul ElliotChairman and CEOJun 02 '26Sale8.2983,758694,3549,663,424Jun 03
Mann Paul ElliotChairman and CEOJun 01 '26Sale7.8883,758660,0139,747,182Jun 03
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.